Table 7. Adverse reactions in patients treated with amivantamab.
Risk level | Adverse reaction |
High risk ≥15% | General disorders and administrative site conditions (17%); Injuries, poisonings, and complications (17%). |
Medium risk 5-15 | Gastrointestinal disorders (5%); Infections and infestations (7%); Benign neoplasms (6%) |
Low risk ≤5% | Blood and lymphatic system disorders (1%); Cardiac disorders (2%); Eye disorders (1%); Immune system disorders (1%); Metabolism and nutrition disorders (1%) |